Literature DB >> 20033706

Fragile histidine triad protein: structure, function, and its association with tumorogenesis.

Md Imtaiyaz Hassan1, Abdullah Naiyer, Faizan Ahmad.   

Abstract

BACKGROUND: The human fragile histidine triad (FHIT) gene is a putative tumor suppressor gene, which is located at chromosome region 3p14.2. It was suggested that the loss of heterozygosity (LOH), homozygous deletions, and abnormal expression of the FHIT gene were involved in several types of human malignancies.
MATERIALS AND METHODS: To determine the role of FHIT in various cancers, we have performed structural and functional analysis of FHIT in detail. RESULTS AND DISCUSSION: The protein FHIT catalyzes the Mg(2+) dependent hydrolysis of P1-5 cent-O-adenosine-P3-5 cent-O-adenosine triphosphate, Ap3A, to AMP, and ADP. The reaction is thought to follow a two-step mechanism. Histidine triad proteins, named for a motif related to the sequence H-cent-H-cent-H-cent-cent- (cent, a hydrophobic amino acid), belong to superfamily of nucleotide hydrolases and transferases. This enzyme acts on the R-phosphate of ribonucleotides, and contain a approximately 30-kDa domain that is typically a homodimer of approximately 15 kDa polypeptides with catalytic site.
CONCLUSION: Here we have gathered information is known about biological activities of FHIT, the structural and biochemical bases for their functions. Our approach may provide a comparative framework for further investigation of FHIT.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20033706     DOI: 10.1007/s00432-009-0751-9

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  174 in total

Review 1.  Chromosomal fragile sites.

Authors:  G R Sutherland
Journal:  Genet Anal Tech Appl       Date:  1991-09

2.  FRA3B extends over a broad region and contains a spontaneous HPV16 integration site: direct evidence for the coincidence of viral integration sites and fragile sites.

Authors:  C M Wilke; B K Hall; A Hoge; W Paradee; D I Smith; T W Glover
Journal:  Hum Mol Genet       Date:  1996-02       Impact factor: 6.150

3.  The Saccharomyces cerevisiae RAD9, RAD17, RAD24 and MEC3 genes are required for tolerating irreparable, ultraviolet-induced DNA damage.

Authors:  A G Paulovich; C D Armour; L H Hartwell
Journal:  Genetics       Date:  1998-09       Impact factor: 4.562

4.  The FHIT gene is alternatively spliced in normal kidney and renal cell carcinoma.

Authors:  X Luan; G Shi; M Zohouri; W Paradee; D I Smith; H J Decker; L A Cannizzaro
Journal:  Oncogene       Date:  1997-07-03       Impact factor: 9.867

5.  Nicotine induces the fragile histidine triad methylation in human esophageal squamous epithelial cells.

Authors:  Toshiya Soma; Junichi Kaganoi; Atsushi Kawabe; Kan Kondo; Masayuki Imamura; Yutaka Shimada
Journal:  Int J Cancer       Date:  2006-09-01       Impact factor: 7.396

6.  Loss of FHIT expression in transitional cell carcinoma of the urinary bladder.

Authors:  R Baffa; L G Gomella; A Vecchione; P Bassi; K Mimori; J Sedor; C M Calviello; M Gardiman; C Minimo; S E Strup; P A McCue; A J Kovatich; F Pagano; K Huebner; C M Croce
Journal:  Am J Pathol       Date:  2000-02       Impact factor: 4.307

7.  Ubc9-induced inhibition of diadenosine triphosphate hydrolase activity of the putative tumor suppressor protein Fhit.

Authors:  Filip Golebiowski; Aneta Szulc; Andrzej Szutowicz; Tadeusz Pawelczyk
Journal:  Arch Biochem Biophys       Date:  2004-08-15       Impact factor: 4.013

8.  DNA polymerase alpha inhibition by aphidicolin induces gaps and breaks at common fragile sites in human chromosomes.

Authors:  T W Glover; C Berger; J Coyle; B Echo
Journal:  Hum Genet       Date:  1984       Impact factor: 4.132

9.  Effect of aberrant promoter methylation of FHIT and RASSF1A genes on susceptibility to cervical cancer in a North Indian population.

Authors:  M Kausar Neyaz; R Suresh Kumar; Showket Hussain; Samar H Naqvi; Indu Kohaar; Nisha Thakur; Veena Kashyap; Bhudev C Das; Syed Akhtar Husain; Mausumi Bharadwaj
Journal:  Biomarkers       Date:  2008-09       Impact factor: 2.658

10.  Nit1 and Fhit tumor suppressor activities are additive.

Authors:  Jin Sun; Hiroshi Okumura; Martha Yearsley; Wendy Frankel; Louise Y Fong; Teresa Druck; Kay Huebner
Journal:  J Cell Biochem       Date:  2009-08-15       Impact factor: 4.429

View more
  9 in total

1.  Abnormal FHIT protein expression may be correlated with poor prognosis in gastric cancer: a meta-analysis.

Authors:  He-Ling Wang; Ping-Yi Zhou; Peng Liu; Yu Zhang
Journal:  Tumour Biol       Date:  2014-04-12

2.  Integrative genome analyses identify key somatic driver mutations of small-cell lung cancer.

Authors:  Martin Peifer; Lynnette Fernández-Cuesta; Martin L Sos; Julie George; Danila Seidel; Lawryn H Kasper; Dennis Plenker; Frauke Leenders; Ruping Sun; Thomas Zander; Roopika Menon; Mirjam Koker; Ilona Dahmen; Christian Müller; Vincenzo Di Cerbo; Hans-Ulrich Schildhaus; Janine Altmüller; Ingelore Baessmann; Christian Becker; Bram de Wilde; Jo Vandesompele; Diana Böhm; Sascha Ansén; Franziska Gabler; Ines Wilkening; Stefanie Heynck; Johannes M Heuckmann; Xin Lu; Scott L Carter; Kristian Cibulskis; Shantanu Banerji; Gad Getz; Kwon-Sik Park; Daniel Rauh; Christian Grütter; Matthias Fischer; Laura Pasqualucci; Gavin Wright; Zoe Wainer; Prudence Russell; Iver Petersen; Yuan Chen; Erich Stoelben; Corinna Ludwig; Philipp Schnabel; Hans Hoffmann; Thomas Muley; Michael Brockmann; Walburga Engel-Riedel; Lucia A Muscarella; Vito M Fazio; Harry Groen; Wim Timens; Hannie Sietsma; Erik Thunnissen; Egbert Smit; Daniëlle A M Heideman; Peter J F Snijders; Federico Cappuzzo; Claudia Ligorio; Stefania Damiani; John Field; Steinar Solberg; Odd Terje Brustugun; Marius Lund-Iversen; Jörg Sänger; Joachim H Clement; Alex Soltermann; Holger Moch; Walter Weder; Benjamin Solomon; Jean-Charles Soria; Pierre Validire; Benjamin Besse; Elisabeth Brambilla; Christian Brambilla; Sylvie Lantuejoul; Philippe Lorimier; Peter M Schneider; Michael Hallek; William Pao; Matthew Meyerson; Julien Sage; Jay Shendure; Robert Schneider; Reinhard Büttner; Jürgen Wolf; Peter Nürnberg; Sven Perner; Lukas C Heukamp; Paul K Brindle; Stefan Haas; Roman K Thomas
Journal:  Nat Genet       Date:  2012-09-02       Impact factor: 38.330

3.  Re-splicing of mature mRNA in cancer cells promotes activation of distant weak alternative splice sites.

Authors:  Toshiki Kameyama; Hitoshi Suzuki; Akila Mayeda
Journal:  Nucleic Acids Res       Date:  2012-06-06       Impact factor: 16.971

Review 4.  The clinicopathological significance of FHIT hypermethylation in non-small cell lung cancer, a meta-analysis and literature review.

Authors:  Wei Yan; Ning Xu; Xiang Han; Xiao-Ming Zhou; Bei He
Journal:  Sci Rep       Date:  2016-01-22       Impact factor: 4.379

Review 5.  The clinicopathological significance and ethnic difference of FHIT hypermethylation in non-small-cell lung carcinoma: a meta-analysis and literature review.

Authors:  Xiaoyu Wu; Guannan Wu; Xuequan Yao; Gang Hou; Feng Jiang
Journal:  Drug Des Devel Ther       Date:  2016-02-15       Impact factor: 4.162

6.  Metabolic Evaluation of Urine from Patients Diagnosed with High Grade (HG) Bladder Cancer by SPME-LC-MS Method.

Authors:  Kamil Łuczykowski; Natalia Warmuzińska; Sylwia Operacz; Iga Stryjak; Joanna Bogusiewicz; Julia Jacyna; Renata Wawrzyniak; Wiktoria Struck-Lewicka; Michał J Markuszewski; Barbara Bojko
Journal:  Molecules       Date:  2021-04-11       Impact factor: 4.411

Review 7.  Therapeutic Potential of Ursolic Acid in Cancer and Diabetic Neuropathy Diseases.

Authors:  Manzar Alam; Sabeeha Ali; Sarfraz Ahmed; Abdelbaset Mohamed Elasbali; Mohd Adnan; Asimul Islam; Md Imtaiyaz Hassan; Dharmendra Kumar Yadav
Journal:  Int J Mol Sci       Date:  2021-11-10       Impact factor: 5.923

Review 8.  The clinicopathological significance and drug target potential of FHIT in breast cancer, a meta-analysis and literature review.

Authors:  Yunshu Su; Xiaoli Wang; Jun Li; Junming Xu; Lijun Xu
Journal:  Drug Des Devel Ther       Date:  2015-10-01       Impact factor: 4.162

9.  Toxoplasma Modulates Signature Pathways of Human Epilepsy, Neurodegeneration & Cancer.

Authors:  Huân M Ngô; Ying Zhou; Hernan Lorenzi; Kai Wang; Taek-Kyun Kim; Yong Zhou; Kamal El Bissati; Ernest Mui; Laura Fraczek; Seesandra V Rajagopala; Craig W Roberts; Fiona L Henriquez; Alexandre Montpetit; Jenefer M Blackwell; Sarra E Jamieson; Kelsey Wheeler; Ian J Begeman; Carlos Naranjo-Galvis; Ney Alliey-Rodriguez; Roderick G Davis; Liliana Soroceanu; Charles Cobbs; Dennis A Steindler; Kenneth Boyer; A Gwendolyn Noble; Charles N Swisher; Peter T Heydemann; Peter Rabiah; Shawn Withers; Patricia Soteropoulos; Leroy Hood; Rima McLeod
Journal:  Sci Rep       Date:  2017-09-13       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.